Challenging Results

Category

University of Washington & Bill & Melinda Gates Foundation Study Leads to Conclusion: Hydroxychloroquine Not Effective in Preventing SARS-CoV-2 Infection

A recent study out of University of Washington School of Medicine in Seattle further weakens the case for hydroxychloroquine as a means to prevent SARS-CoV-2 infection. That is, based on a randomized, controlled trial, those individuals taking hydroxychloroquine while...

Cardiovascular Research Foundation: No Mortality Risk or Benefit Associated with Drug-Coated Devices in the Treatment of Peripheral Artery Disease

A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of...

Massachusetts General Hospital Completes Study & Concludes Tocilizumab Not Helpful for Hospitalized COVID-19 Patients

TrialSite has reported on a few different study results indicating that Roche’s Actemra (tocilizumab), an IL-6 inhibitor, doesn’t help to lower the death rate for hospitalized patients infected with severe to critical COVID-19. Now study results, recently published in...

Pin It on Pinterest